Author

Britt Olaug Lindestad

University of Oslo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:long-read sequencing· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Anna Zofia KomisarczukiD· 1 shared Antti TuhkalaiD· 1 shared Camilla Schalin‐JänttiiD· 1 shared Carolina Wieczorek ErvikiD· 1 shared Eero Tölö· 1 shared Eira LeinoneniD· 1 shared Eivind ValeniD· 1 shared Emma Maria HaapaniemiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Anna Zofia KomisarczukORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

T cell correction pipeline for Inborn Errors of Immunity

Katariina Mamia, Sólrún Kolbeinsdóttir, Kornel Labun, Zhuokun Li, Anna Zofia Komisarczuk, Salla Keskitalo, Ganna Reint, Frida Loe Haugen, Britt Olaug Lindestad, Siv Skundberg Jensen, Thea Johanne Gjerdingen, Antti Tuhkala, Carolina Wieczorek Ervik, Pavel Kopcil, Nail Fatkhutdinov, , Emma Maria Haapaniemi

This paper presents a T cell gene correction pipeline using CRISPR/Cas9 and HDR to correct monogenic mutations in IEI models, achieving up to 80% bi-allelic editing with no detectable off-target effects.

Molecular Therapy · Aug 12, 2025Peer-reviewedBioengineering